Swallowing loss

- Last updated on GMT

Related tags: Diabetes mellitus, Insulin

Losses continue for buccal drug delivery company Generex
Biotechnology with the company yesterday reporting a net loss of
$4.6 million (€4.3m), or $(27) per share for the quarter ended
January 31, 2003 - compared to a net loss of $3.8 million (€3.6m),
or $(0.21) per share, for the same period in 2002.

Losses continue for buccal drug delivery company Generex Biotechnology with the company yesterday reporting a net loss of $4.6 million (€4.3m), or $(27) per share for the quarter ended January 31, 2003 - compared to a net loss of $3.8 million (€3.6m, or $(0.21) per share, for the same period in 2002.

The company attributed an increase in general and administrative expenses, primarily to an issuance of warrants and options to various advisors and consultants, for the increase in net loss.

Anna Gluskin, president and CEO of Generex, remained upbeat. "We are continuing to receive encouraging clinical results for Oralin, our oral insulin formulation which is delivered for absorption by the mucous membranes of the mouth by our proprietary RapidMist device,"​ she said.

" In the second half of this fiscal year, we are looking forward to further progress for our technology platform for the treatment of diabetes. We believe that our current cash position is sufficient to meet our working capital needs for at least the next 12 months, based on the pace of our current development activities."

Related news

Related products

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Q2 Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Follow us

Products

View more

Webinars